❓How did AstraZeneca lose the vaccine race?
💉The Oxford jab has been dropped from booster plans after months of adverse headlines. Is there any way back?
🧵👇
telegraph.co.uk/health-fitness…
💉The Oxford jab has been dropped from booster plans after months of adverse headlines. Is there any way back?
🧵👇
telegraph.co.uk/health-fitness…
❌The UK has sidelined its "homegrown" Covid vaccine.
🇬🇧Last week, it was confirmed that Britain’s programme offering third jabs to the most vulnerable will use Pfizer and Moderna jabs instead
🇬🇧Last week, it was confirmed that Britain’s programme offering third jabs to the most vulnerable will use Pfizer and Moderna jabs instead
💉As the company looks back today, it will know that somehow its project has soured, turning what should have been a reputational triumph into something at times approaching a disaster...
📸Daniel Pockett/EPA-EFE/Shutterstock
📸Daniel Pockett/EPA-EFE/Shutterstock
➡️November 2020 turned out to be the month the world was waiting for.
#Pfizer revealed its vaccine was 90 per cent effective at preventing infection. Exactly a week later, #Moderna said its vaccine was 94.5 per cent effective…
#Pfizer revealed its vaccine was 90 per cent effective at preventing infection. Exactly a week later, #Moderna said its vaccine was 94.5 per cent effective…
📉Then came AstraZeneca’s turn. By comparison, the results were a bit of a disappointment – only 70 per cent effective
While Pfizer and Moderna had clear studies, AstraZeneca’s trial managed to introduce doubt about efficacy in three variables:
❌Age
❌Dose strength
❌Time between doses
❌Age
❌Dose strength
❌Time between doses
➡️Almost as soon as the vaccine was first authorised, it became clear that AstraZeneca would not be able to deliver as many doses as it hoped
The EU found itself receiving less than a quarter of the 120m doses it expected in the first quarter
The EU found itself receiving less than a quarter of the 120m doses it expected in the first quarter
🇫🇷It was Emmanuel #Macron who, on January 29, dismissed the #AstraZeneca vaccine as "quasi-ineffective" for over-65s
Soon an issue emerged that made supply wrangles fade into insignificance.
🔴The first reports came from Austria in early March. A 49 year-old woman had died. Another, 35, was in hospital. Both had suffered severe blood clots after receiving the AstraZeneca jab
🔴The first reports came from Austria in early March. A 49 year-old woman had died. Another, 35, was in hospital. Both had suffered severe blood clots after receiving the AstraZeneca jab
📊A poll in March found that just 23 per cent of people in France considered the AstraZeneca jab safe
As summer ends, the fate of the AstraZeneca jab might seem sealed…
However, a couple of bright reasons for hope shine out
However, a couple of bright reasons for hope shine out
➡️Low-income countries are awaiting their first jabs and AstraZeneca, unlike its rivals, is cheap and easy to transport.
The second hopeful glow for the company is strategic. It has been a rollercoaster ride, but investors are already looking at the positives
📸: AstraZeneca
The second hopeful glow for the company is strategic. It has been a rollercoaster ride, but investors are already looking at the positives
📸: AstraZeneca
🔎Read more on why the AstraZeneca jab has reasons for hope as we move into autumn here 👇
telegraph.co.uk/health-fitness…
telegraph.co.uk/health-fitness…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
